NOVOCURE LIMITED

(NVCR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about NOVOCURE LIMITED
06/21NovoCure Enrolls First Patient in Study of Tumor Treating Fields, Keytruda Combination ..
MT
06/21Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields T..
BU
06/21Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields T..
CI
06/06HC Wainwright Initiates NovoCure at Buy, Sets Price Target at $115
MT
06/03Novocure Falls 5%, Zai Lab Rises 8%; Companies Report Study Results
DJ
06/03NOVOCURE : Press Release of NovoCure Limited, dated June 3, 2022 - Form 8-K
PU
06/03Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Field..
BU
06/03Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Field..
CI
05/26NOVOCURE : Announces Clinical Collaboration with MSD on a Registrational-Intent Study to E..
PU
05/26NovoCure Teams Up With Merck to Study Tumor Treating Fields Combined With Keytruda to T..
MT
05/26Novocure Announces Clinical Collaboration with MSD on a Registrational-Intent Study to ..
BU
05/26NovoCure Limited Announces Clinical Collaboration with MSD on a Registrational-Intent S..
CI
05/16NovoCure's Shares Rise After HC Wainwright Initiates Coverage at Buy
MT
05/16HC Wainwright Initiates NovoCure at Buy With $115 Price Target
MT
05/13Piper Sandler Adjusts NovoCure's Price Target to $100 From $125, Reiterates Overweight ..
MT
More most relevant news
All news about NOVOCURE LIMITED
06/21NovoCure Enrolls First Patient in Study of Tumor Treating Fields, Keytruda Combination ..
MT
06/21Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields T..
BU
06/21Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields T..
CI
06/10NOVOCURE LTD : Change in Directors or Principal Officers, Amendments to Articles of Inc. o..
AQ
06/06HC Wainwright Initiates NovoCure at Buy, Sets Price Target at $115
MT
06/03Novocure Falls 5%, Zai Lab Rises 8%; Companies Report Study Results
DJ
06/03Zai Lab, Novocure's Phase 2 Study of Gastric Cancer Combination Therapy Meets Primary E..
MT
06/03NOVOCURE : Press Release of NovoCure Limited, dated June 3, 2022 - Form 8-K
PU
06/03NOVOCURE LTD : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
06/03Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Field..
BU
More news
News in other languages on NOVOCURE LIMITED
06/21NovoCure enrôle le premier patient dans l'étude sur les champs de traitement des tumeur..
06/21Novocure enrôle le premier patient dans KEYNOTE-B36, une étude pilote sur les champs de..
06/03L'étude de phase 2 de Zai Lab et Novocure sur la thérapie combinée contre le cancer gas..
06/03Novocure et Zai Lab annoncent que l'étude pilote de phase 2 EF-31, qui évalue les champ..
05/26MISE À JOUR SECTORIELLE : Les actions du secteur de la santé propulsées à la hausse près d..
05/26MISE À JOUR SECTORIELLE : Les actions du secteur de la santé en hausse jeudi
05/26NovoCure s'associe à Merck pour étudier les champs de traitement des tumeurs combinés à..
05/26NovoCure Limited annonce une collaboration clinique avec MSD dans le cadre d'une étude ..
05/16Les actions de NovoCure augmentent après que HC Wainwright ait initié une couverture à ..
04/28La perte nette de NovoCure au 1er trimestre est stable, les revenus augmentent
More news
Analyst Recommendations on NOVOCURE LIMITED
06/06HC Wainwright Initiates NovoCure at Buy, Sets Price Target at $115
MT
05/16HC Wainwright Initiates NovoCure at Buy With $115 Price Target
MT
05/13Piper Sandler Adjusts NovoCure's Price Target to $100 From $125, Reiterates Overweight ..
MT
04/04Evercore ISI Adjusts Price Target for NovoCure to $82 From $62, Maintains In-Line Ratin..
MT
02/08Loop Capital Starts NovoCure at Buy With $200 Price Target
MT
More recommendations
Press releases
06/21Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields T..
BU
06/10NOVOCURE LTD : Change in Directors or Principal Officers, Amendments to Articles of Inc. o..
AQ
06/03NOVOCURE : Press Release of NovoCure Limited, dated June 3, 2022 - Form 8-K
PU
06/03NOVOCURE LTD : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
06/03Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Field..
BU
More press releases
Upcoming event on NOVOCURE LIMITED